CHICAGO — Hearing loss can affect anyone, at any time. But it can be especially frightening for someone who suddenly starts to lose his hearing during adulthood. Tom Groves, 77, first noticed his diminishing hearing when he was in his early 40s. He was unable to hold conversations with large groups of people; found it nearly impossible to socialize in high-background noise environments like restaurants; and couldn’t enjoy radio, TV and movies unless they were captioned. Now, Groves is hearing much better than he has in 30 years, thanks to an experimental hybrid cochlear implant.
Northwestern Memorial Hospital is one of nine centers in the U.S., and the only in Illinois, that is participating in a study investigating the effectiveness of a new cochlear implant device that aims to restore hearing for individuals with high-frequency hearing loss and functional low-frequency hearing.
This group of patients doesn’t meet the criteria for conventional cochlear implants because they have near perfect residual hearing in low pitches that allows them to perform well on tests used to determine candidacy for traditional implants. However, their hearing in high pitches is so poor that a hearing aid is not helpful, making them ideally suited for the hybrid implant which addresses both issues.
“We are hopeful that the hybrid cochlear implant will provide a subset of people who were previously not candidates for an implantable device the opportunity to test the device to determine if they can experience sound again,” said Northwestern Medicine neurotologist Andrew Fishman, MD, principal investigator of the study, staff in the departments of otolaryngology and neurosurgery at Northwestern University’s Feinberg School of Medicine, and Mr. Groves’ cochlear implant surgeon. “The potential for patients with a significant amount of residual hearing, but a large amount of high-frequency hearing loss, to have an alternative to hearing aids would be a great improvement to what is currently available.”
Cochlear implants were FDA approved in 1984 as a treatment option for restoring hearing in people with severe and profound hearing loss. The surgical implant system is designed to stimulate the auditory nerve by bypassing damaged parts of the ear. A small battery-operated mini “computer” and microphone are worn on the outside of the ear and convert sounds into electric signals. The signals are then transmitted to implant electrodes in the cochlea, which stimulate the nerve endings so sound can be perceived by the brain.
The hybrid cochlear implant works in the same way as traditional cochlear implants, stimulating nerve endings in the cochlear so that high-pitched sounds can be heard. In addition, it also involves amplification for low-pitched sounds, similar to a hearing aid. Like traditional cochlear implants, the hybrid version is worn outside the ear and converts sounds into acoustic and electric signals.
“The surgical implantation of cochlear devices is typically done on an outpatient basis, and usually with non-serious complications, aside from mild discomfort following surgery,” said Northwestern Medicine otolaryngologist Alan Micco, MD, co-investigator of the study and chief of otology/neurotology at the Feinberg School of Medicine. “A few weeks following surgery, the activation process and fine-tuning take place to determine what audio thresholds work best for the individual, and sounds can usually be perceived shortly thereafter.”
Post-activation evaluations take place at three, six and 12 months following the initial activation process to assess progress of the cochlear implant. An audiologist will also test the implant to determine if participants are able to understand words, sentences in noisy and quiet environments, as well as music recognition.
A few months post-surgery, Groves is happy to have some of his hearing restored. “I’m very excited and encouraged by my experience with the implant. I know I’m hearing better than I have for many, many years and for that I’m very grateful.”
For more information or to schedule an appointment, call the physician referral line at (877) 926-4664.
About Northwestern Memorial HealthCare
Northwestern Memorial HealthCare is the parent corporation of Chicago’s Northwestern Memorial Hospital, an 854-bed academic medical center hospital and Northwestern Lake Forest Hospital, a 215-bed community hospital located in Lake Forest, Illinois.
About Northwestern Memorial Hospital
Northwestern Memorial is one of the country’s premier academic medical center hospitals and is the primary teaching hospital of the Northwestern University Feinberg School of Medicine. Along with its Prentice Women’s Hospital and Stone Institute of Psychiatry, the hospital comprises 854 beds, 1,603 affiliated physicians and 7,144 employees. Northwestern Memorial is recognized for providing exemplary patient care and state-of-the art advancements in the areas of cardiovascular care; women’s health; oncology; neurology and neurosurgery; solid organ and soft tissue transplants and orthopaedics.
Northwestern Memorial possesses nursing Magnet Status, the nation’s highest recognition for patient care and nursing excellence, and it is listed in 12 clinical specialties in U.S. News & World Report’s 2010 “America’s Best Hospitals” guide. For 10 years running, it has been rated among the “100 Best Companies for Working Mothers” guide by Working Mother magazine. The hospital is a recipient of the prestigious National Quality Health Care Award and has been chosen by Chicagoans as the Consumer Choice according to the National Research Corporation’s annual survey for 11 years.